Nirmatrelvir is an azabicyclohexane compound that functions as an inhibitor of the SARS-CoV-2 main protease. It is an orally administered active pharmaceutical ingredient used in combination with ritonavir as part of the COVID-19 treatment regimen Paxlovid.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2628280-40-8
Descyano nirmatrelvir acetamide
pharmaceutical intermediate
N-Nitroso-Folic Acid
pharmaceutical raw material
5-Desethoxy,-5-Methoxy-Finerenone
pharmaceutical raw material
1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethane-1-sulfonic acid
pharmaceutical raw material
Calquence
pharmaceutical raw material
(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
LIENCHBZNNMNKG-OJFNHCPVSA-N
CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C